Purchase Order 75D30124P19851
- Not listed
- This is a $24,995.00 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The contract does not have a set-aside designation. The award is for the provision of unspecified products and services related to Bio-Rad's capabilities in providing laboratory equipment, reagents, and consumables for biomedical research and clinical...
- The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order to Bio-Rad Laboratories, Inc. for the procurement of a BioRad CFX Opus 96 Dx real-time PCR system, associated training, and a computer. The total value of the contract is $45,250.50, with a delivery date 30 days after award. This sole-source acquisition was not set aside for any specific business size or type. Bio-Rad Laboratories is a leading manufacturer of specialized laboratory equipment, reagents,...
- The Centers for Disease Control and Prevention (CDC) awarded a $22,944.00 firm-fixed-price purchase order to Bio-Rad Laboratories, Inc. for PCR system equipment maintenance. The contract has an ultimate completion date of April 22, 2025. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for life science research and clinical diagnostics, and serves as a prime contractor to numerous federal agencies, including the National Institutes of Health (NIH),...
- This federal contract award is for a BIO-RAD 200 SYSTEM with a ceiling value of $62,720.00. The contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility, a civilian agency, to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The contract is a Firm Fixed Price Purchase Order with a completion date of September 24, 2024. No set-aside was used for this award. Bio-Rad Laboratories, Inc. is a leading manufacturer and supplier of specialized products...
- This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc. for annual service to maintain, calibrate, and repair laboratory equipment manufactured by Bio-Rad that is used to conduct and analyze HIV prevention and transmission scientific studies. The contract is valued at $135,768.00 and runs through June 30, 2025. No set-aside designation was used for this sole source procurement, which was authorized under FAR...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Bio-Rad Laboratories, Inc. Life Science Group Division, a for-profit manufacturer of biotechnology products and laboratory equipment. The $103,398.60 firm-fixed-price purchase order is for the delivery of a DDPCR SYSTEM. No set-aside designation was indicated. Bio-Rad Laboratories holds a 5-year, $1 billion blanket purchase agreement with the National Institutes of...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,742.00 firm fixed-price purchase order contract to Bio-Rad Laboratories, Inc. Life Science Group Division for the provision of laboratory supplies. The contract has an ultimate completion date of September 21, 2024. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostic products. As the parent company, Bio-Rad Laboratories, Inc. holds several significant federal Indefinite Delivery...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $28,637.70 firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for CFX OPUS 96 under contract number CFX OPUS 96. As the prime contractor, Bio-Rad Laboratories will deliver their CFX OPUS 96 product to the CDC location in Hercules, California. Performance is required between September 21-30, 2023. No subcontractors or set aside designations were...
- This is a $124,117.10 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Bio Rad Laboratories Inc., a global manufacturer of life science research and clinical diagnostic products. The contract is for the supply of unspecified products and services, and does not have a set-aside designation. Bio Rad Laboratories Inc. is a subsidiary of the parent company Bio-Rad Laboratories, Inc., which serves as a prime contractor on numerous federal...
- This $95,000.00 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Bio-Rad Laboratories, Inc. Life Science Group Division for LABORATORY SUPPLIES. The contract has no set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics equipment, reagents, and consumables. It has established relationships with multiple federal agencies, including the CDC, through prime contract...
This federal contract award is for the purchase of Bio-Rad OPUS instruments by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases Influenza Division (NCIRD/ID). The contract, valued at $230,810.00, is a firm fixed-price purchase order awarded to Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products. The purpose of this sole-source acquisition is to evaluate the CDC's FDA-cleared and FDA-approved in vitro diagnostic assays for influenza and SARS-CoV-2 on the Bio-Rad OPUS DX instrument, which uses reverse-transcriptase real-time polymerase chain reaction (rRT-PCR) technology. As the only known manufacturer of the OPUS DX instruments, Bio-Rad Laboratories, Inc. was selected for this procurement, which did not involve any set-aside designations. The contract has an ultimate completion date of January 28, 2025.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Purchase of BioRad OPUS Instrument for GDT | 75D301-24-Q-78076 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Solicitation 2/2 | 8/28/24, 12:13 PM | |
Intent to Sole Source Bio-Rad OPUS DX Instruments | 75D301-24-Q-78076 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Pre-Solicitation 1/2 | 7/23/24, 4:53 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 11/11/24 | |
| Not listed | Not listed | $230.8k | 9/4/24 |